These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24722018)

  • 1. [System of microcirculation, markers of vascular wall damage and systematicity of the process in rheumatic diseases].
    Shilkina NP; Butusova SV; Driazhenkova IV
    Angiol Sosud Khir; 2014; 20(1):27-34. PubMed ID: 24722018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Endothelial dysfunction in rheumatic patients].
    Shilkina NP; Butusova SV
    Klin Med (Mosk); 2013; 91(4):58-61. PubMed ID: 23879057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Markers of endothelial activation in rheumatoid arthritis].
    Shilikina NP; Yunonin IE; Vinogradov AA; Butusova SV
    Ter Arkh; 2012; 84(8):29-32. PubMed ID: 22994085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis.
    Kluz J; Kopeć W; Jakobsche-Policht U; Adamiec R
    Int Angiol; 2009 Jun; 28(3):192-201. PubMed ID: 19506538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentraxin 3 as a biomarker of local inflammatory response to vascular injury in systemic lupus erythematosus.
    Cieślik P; Hrycek A
    Autoimmunity; 2015 Jun; 48(4):242-50. PubMed ID: 25401491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cerebral perfusion, arterial hypertension and endothelial dysfunction in rheumatoid arthritis].
    Shilkina NP; Spirin NN; Yunonin IE; Vinogradov AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(3. Vyp. 2):68-75. PubMed ID: 31184627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Markers of vascular endothelium activation in gout].
    Lapkina NA; Baranov AA; Barskova VG; Abaĭtova NE; Iakunina IA
    Ter Arkh; 2005; 77(5):62-5. PubMed ID: 15989007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endothelial damage and circadian blood pressure profile in rheumatoid arthritis].
    Shilkina NP; Yunonin IE; Butusova SV; Mikhailova EV; Vinogradov AA
    Ter Arkh; 2019 May; 91(5):89-95. PubMed ID: 32598682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Laboratory indicators of endothelial involvement in rheumatic diseases associated with vasculitis in children].
    Dolezalová P; Telekesová P; Nĕmcová D; Bĕlorová J; Kvasnicka J; Hoza J
    Cas Lek Cesk; 2003; 142(10):615-9. PubMed ID: 14635427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial cell activation in cutaneous vasculitis.
    Jurd KM; Stephens CJ; Black MM; Hunt BJ
    Clin Exp Dermatol; 1996 Jan; 21(1):28-32. PubMed ID: 8689765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Microcirculatory disorders in systemic lupus erythematosus].
    Kozlova LK; Bagirova VV
    Ter Arkh; 2003; 75(5):41-6. PubMed ID: 12847897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble adhesion molecules in pediatric rheumatic diseases.
    Bloom BJ; Miller LC; Blier PR
    J Rheumatol; 2002 Apr; 29(4):832-6. PubMed ID: 11950029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiopoietin-2, endothelial dysfunction and renal involvement in patients with systemic lupus erythematosus.
    El-Banawy HS; Gaber EW; Maharem DA; Matrawy KA
    J Nephrol; 2012; 25(4):541-50. PubMed ID: 21956768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity.
    Kuryliszyn-Moskal A; Ciolkiewicz M; Klimiuk PA; Sierakowski S
    Scand J Rheumatol; 2009; 38(1):38-45. PubMed ID: 18991188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rheumatoid arthritis, inflammation, and atherosclerosis].
    Hürlimann D; Enseleit F; Ruschitzka F
    Herz; 2004 Dec; 29(8):760-8. PubMed ID: 15599672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular responsiveness in the microcirculation of patients with systemic lupus erythematosus is not impaired.
    de Leeuw K; Blaauw J; Smit A; Kallenberg C; Bijl M
    Lupus; 2008 Nov; 17(11):1010-7. PubMed ID: 18852225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis.
    Dessein PH; Joffe BI; Singh S
    Arthritis Res Ther; 2005; 7(3):R634-43. PubMed ID: 15899050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation and microvascular and macrovascular endothelial dysfunction in rheumatoid arthritis: effect of treatment.
    Foster W; Carruthers D; Lip GY; Blann AD
    J Rheumatol; 2010 Apr; 37(4):711-6. PubMed ID: 20156948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does reduction of disease activity improve early markers of cardiovascular disease in newly diagnosed rheumatoid arthritis patients?
    de Groot L; Jager NA; Westra J; Smit AJ; Kallenberg CG; Posthumus MD; Bijl M
    Rheumatology (Oxford); 2015 Jul; 54(7):1257-61. PubMed ID: 25587178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.